InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+30.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Kirsch Arthur S, 董事. Officer active across 6 companies, notably Kadmon Holdings, Inc.. Cumulatively, 9 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €226k. History available since 13 May 2021. The latest transaction was disclosed on 7 July 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kirsch Arthur S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
10,000 股@ US$13.300.030% mcap100.0% 占其流量Common StockSEC:0001290976-26-000004:0
标准退出：2026年10月5日 (T+90)
18,396 股0Common StockSEC:0001104659-25-061190:0
20,359 股0Common StockSEC:0001104659-24-074472:0
30,000 股@ US$4.24100.0% 占其流量Common StockSEC:0001104659-21-138087:0
标准退出：2022年2月8日 (T+90)
30,000 股@ US$9.5080.6% 占其流量Common StockSEC:0001104659-21-136408:0
20,000 股@ US$3.5819.4% 占其流量Common stockSEC:0001593968-21-001331:0
64,719 股Common SharesSEC:0001104659-16-095173:0
6,107 股Common StockSEC:0001104659-16-094738:0
6,107 股Common StockSEC:0001104659-16-091019:0
9 条申报中的 9 条
About Kirsch Arthur S
Arthur S. Kirsch serves as a Board Member at Kadmon Holdings, Inc. and Liquidia Corp. In this role, he oversees the operations of these companies and participates in strategic decision-making. His expertise in the biopharmaceutical sector allows him to provide significant contributions to the board.
